Decibel Therapeutics Statistics Share Statistics Decibel Therapeutics has 25.13M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 25.13M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 13.4M Failed to Deliver (FTD) Shares 14,291 FTD / Avg. Volume 6.66%
Short Selling Information The latest short interest is 110.95K, so 0.44% of the outstanding
shares have been sold short.
Short Interest 110.95K Short % of Shares Out 0.44% Short % of Float 0.65% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.81 and the forward
PE ratio is null.
Decibel Therapeutics's PEG ratio is
-0.14.
PE Ratio -0.81 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.63 P/FCF Ratio -0.89 PEG Ratio -0.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Decibel Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.81,
with a Debt / Equity ratio of 0.17.
Current Ratio 4.81 Quick Ratio 4.81 Debt / Equity 0.17 Debt / EBITDA -0.22 Debt / FCF -0.24 Interest Coverage -53.66
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-926.54K Employee Count 68 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 240K Effective Tax Rate -0.38%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is -0.4, so Decibel Therapeutics's
price volatility has been lower than the market average.
Beta -0.4 52-Week Price Change n/a 50-Day Moving Average 4.61 200-Day Moving Average 3.72 Relative Strength Index (RSI) 51.68 Average Volume (20 Days) 214,738
Income Statement
Revenue n/a Gross Profit n/a Operating Income -63.96M Net Income -63.01M EBITDA -62.49M EBIT -61.57M Earnings Per Share (EPS) -2.52
Full Income Statement Balance Sheet The company has 34.61M in cash and 14.05M in
debt, giving a net cash position of 20.55M.
Cash & Cash Equivalents 34.61M Total Debt 14.05M Net Cash 20.55M Retained Earnings -277.52M Total Assets 94.39M Working Capital 53.87M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -56.9M
and capital expenditures -463K, giving a free cash flow of -57.36M.
Operating Cash Flow -56.9M Capital Expenditures -463K Free Cash Flow -57.36M FCF Per Share -2.3
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
